Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Real-time observation of flexible domain movements in CRISPR-Cas9.

Osuka S, Isomura K, Kajimoto S, Komori T, Nishimasu H, Shima T, Nureki O, Uemura S.

EMBO J. 2018 Apr 12. pii: e96941. doi: 10.15252/embj.201796941. [Epub ahead of print]

2.

Clinical application of serum anti-Müllerian hormone as an ovarian reserve marker: A review of recent studies.

Iwase A, Osuka S, Goto M, Murase T, Nakamura T, Takikawa S, Kikkawa F.

J Obstet Gynaecol Res. 2018 Mar 8. doi: 10.1111/jog.13633. [Epub ahead of print]

PMID:
29517134
3.

A Case of Serious Eye Injury Caused by a Mistaken Injection of Methylrosaniline Chloride During Vitreous Surgery.

Kimura D, Sato T, Nemoto E, Osuka S, Fujita Y, Fukumoto M, Kida T, Ikeda T.

Ophthalmic Surg Lasers Imaging Retina. 2017 Dec 1;48(12):1010-1015. doi: 10.3928/23258160-20171130-09.

PMID:
29253305
4.

Follicle dynamics: visualization and analysis of follicle growth and maturation using murine ovarian tissue culture.

Murase T, Iwase A, Komatsu K, Bayasula, Nakamura T, Osuka S, Takikawa S, Goto M, Kotani T, Kikkawa F.

J Assist Reprod Genet. 2018 Feb;35(2):339-343. doi: 10.1007/s10815-017-1073-5. Epub 2017 Oct 27.

5.

Retrospective analysis of magnetic resonance imaging for differentiating intraligamentous leiomyomas from subserosal leiomyomas.

Shimizu K, Iwase A, Sakurai Y, Nakamura T, Osuka S, Takikawa S, Goto M, Kikkawa F.

Eur J Obstet Gynecol Reprod Biol. 2017 Aug;215:256-257. doi: 10.1016/j.ejogrb.2017.06.046. Epub 2017 Jul 1. No abstract available.

PMID:
28689575
6.

Cancer therapy: Neutrophils traffic in cancer nanodrugs.

Osuka S, Van Meir EG.

Nat Nanotechnol. 2017 Jul;12(7):616-618. doi: 10.1038/nnano.2017.82. Epub 2017 Jun 19. No abstract available.

PMID:
28650438
7.

Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Chico Ponce de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD.

Cancer Cell. 2017 Jun 12;31(6):737-754.e6. doi: 10.1016/j.ccell.2017.05.005.

PMID:
28609654
8.

Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.

Miyazaki T, Ishikawa E, Matsuda M, Akutsu H, Osuka S, Sakamoto N, Takano S, Yamamoto T, Tsuboi K, Matsumura A.

J Neurooncol. 2017 Jun;133(2):277-285. doi: 10.1007/s11060-017-2451-7. Epub 2017 Apr 26.

PMID:
28447277
9.

IL-36γ signaling controls the induced regulatory T cell-Th9 cell balance via NFκB activation and STAT transcription factors.

Harusato A, Abo H, Ngo VL, Yi SW, Mitsutake K, Osuka S, Kohlmeier JE, Li JD, Gewirtz AT, Nusrat A, Denning TL.

Mucosal Immunol. 2017 Nov;10(6):1455-1467. doi: 10.1038/mi.2017.21. Epub 2017 Mar 22.

10.

Survival of lung cancer patients is prolonged with higher regucalcin gene expression: suppressed proliferation of lung adenocarcinoma A549 cells in vitro.

Yamaguchi M, Osuka S, Shoji M, Weitzmann MN, Murata T.

Mol Cell Biochem. 2017 Jun;430(1-2):37-46. doi: 10.1007/s11010-017-2952-x. Epub 2017 Feb 8.

PMID:
28181135
11.

Overcoming therapeutic resistance in glioblastoma: the way forward.

Osuka S, Van Meir EG.

J Clin Invest. 2017 Feb 1;127(2):415-426. doi: 10.1172/JCI89587. Epub 2017 Feb 1. Review.

12.

Kisspeptin in the Hypothalamus of 2 Rat Models of Polycystic Ovary Syndrome.

Osuka S, Iwase A, Nakahara T, Kondo M, Saito A, Bayasula, Nakamura T, Takikawa S, Goto M, Kotani T, Kikkawa F.

Endocrinology. 2017 Feb 1;158(2):367-377. doi: 10.1210/en.2016-1333.

PMID:
27983870
13.

Involvement of mesosalpinx in endometrioma is a possible risk factor for decrease of ovarian reserve after cystectomy: a retrospective cohort study.

Saito A, Iwase A, Nakamura T, Osuka S, Bayasula, Murase T, Kato N, Ishida C, Takikawa S, Goto M, Kikkawa F.

Reprod Biol Endocrinol. 2016 Oct 28;14(1):72.

14.

Prolonged survival in hepatocarcinoma patients with increased regucalcin gene expression: HepG2 cell proliferation is suppressed by overexpression of regucalcin in vitro.

Yamaguchi M, Osuka S, Weitzmann MN, El-Rayes BF, Shoji M, Murata T.

Int J Oncol. 2016 Oct;49(4):1686-94. doi: 10.3892/ijo.2016.3669. Epub 2016 Aug 23.

PMID:
27633001
15.

Choosing the optimal therapeutic strategy for placental polyps using power Doppler color scoring: Transarterial embolization followed by hysteroscopic resection or expectant management?

Mori M, Iwase A, Osuka S, Kondo M, Nakamura T, Nakahara T, Goto M, Kikkawa F.

Taiwan J Obstet Gynecol. 2016 Aug;55(4):534-8. doi: 10.1016/j.tjog.2014.12.016.

16.

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, Lipp ES, Dunham C, Hukin J, Eisenstat DD, Fulton D, van Landeghem FK, Santi M, van Veelen ML, Van Meir EG, Osuka S, Fan X, Muraszko KM, Tirapelli DP, Oba-Shinjo SM, Marie SK, Carlotti CG, Lee JY, Rao AA, Giannini C, Faria CC, Nunes S, Mora J, Hamilton RL, Hauser P, Jabado N, Petrecca K, Jung S, Massimi L, Zollo M, Cinalli G, Bognár L, Klekner A, Hortobágyi T, Leary S, Ermoian RP, Olson JM, Leonard JR, Gardner C, Grajkowska WA, Chambless LB, Cain J, Eberhart CG, Ahsan S, Massimino M, Giangaspero F, Buttarelli FR, Packer RJ, Emery L, Yong WH, Soto H, Liau LM, Everson R, Grossbach A, Shalaby T, Grotzer M, Karajannis MA, Zagzag D, Wheeler H, von Hoff K, Alonso MM, Tuñon T, Schüller U, Zitterbart K, Sterba J, Chan JA, Guzman M, Elbabaa SK, Colman H, Dhall G, Fisher PG, Fouladi M, Gajjar A, Goldman S, Hwang E, Kool M, Ladha H, Vera-Bolanos E, Wani K, Lieberman F, Mikkelsen T, Omuro AM, Pollack IF, Prados M, Robins HI, Soffietti R, Wu J, Metellus P, Tabori U, Bartels U, Bouffet E, Hawkins CE, Rutka JT, Dirks P, Pfister SM, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Ellison DW, Taylor MD.

J Clin Oncol. 2016 Jul 20;34(21):2468-77. doi: 10.1200/JCO.2015.65.7825. Epub 2016 Jun 6.

17.
18.

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.

Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AAN, Giannini C, Li KKW, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DCY, Seow WT, Chang KTE, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fèvre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobágyi T, Klekner A, László B, Pócza T, Hauser P, Schüller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, López-Aguilar E, Lyden D, Garzia L, Shih DJH, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DTW, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD.

Lancet Oncol. 2016 Apr;17(4):484-495. doi: 10.1016/S1470-2045(15)00581-1. Epub 2016 Mar 12.

19.

Serum pentraxin 3 as a possible marker for mature cystic teratomas.

Ishida C, Iwase A, Osuka S, Goto M, Takikawa S, Nakamura T, Kotani T, Kikkawa F.

Gynecol Endocrinol. 2016 Sep;32(9):733-736. Epub 2016 Mar 10.

PMID:
26965297
20.

Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.

Yamaguchi M, Osuka S, Weitzmann MN, El-Rayes BF, Shoji M, Murata T.

Int J Oncol. 2016 May;48(5):1955-64. doi: 10.3892/ijo.2016.3409. Epub 2016 Feb 25.

PMID:
26935290
21.

Increase of kisspeptin-positive cells in the hypothalamus of a rat model of polycystic ovary syndrome.

Kondo M, Osuka S, Iwase A, Nakahara T, Saito A, Bayasula, Nakamura T, Goto M, Kotani T, Kikkawa F.

Metab Brain Dis. 2016 Jun;31(3):673-81. doi: 10.1007/s11011-016-9807-0. Epub 2016 Feb 11.

PMID:
26864582
22.

Usefulness of the Ultrasensitive Anti-Müllerian Hormone Assay for Predicting True Ovarian Reserve.

Iwase A, Osuka S, Nakamura T, Kato N, Takikawa S, Goto M, Kikkawa F.

Reprod Sci. 2016 Jun;23(6):756-60. doi: 10.1177/1933719115618284. Epub 2015 Nov 26.

PMID:
26614267
23.

Anti-Müllerian hormone levels after laparoscopic cystectomy for endometriomas as a possible predictor for pregnancy in infertility treatments.

Iwase A, Nakamura T, Kato N, Goto M, Takikawa S, Kondo M, Osuka S, Mori M, Kikkawa F.

Gynecol Endocrinol. 2016;32(4):293-7. doi: 10.3109/09513590.2015.1114078. Epub 2015 Nov 23.

PMID:
26597472
24.

Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?

Iwase A, Nakamura T, Osuka S, Takikawa S, Goto M, Kikkawa F.

Reprod Med Biol. 2015 Nov 23;15(3):127-136. doi: 10.1007/s12522-015-0227-3. eCollection 2016 Jul. Review.

25.

Risk stratification by the lower limit of normal of FEV1/FVC for postoperative outcomes in patients with COPD undergoing thoracic surgery.

Osuka S, Hashimoto N, Sakamoto K, Wakai K, Yokoi K, Hasegawa Y.

Respir Investig. 2015 May;53(3):117-23. doi: 10.1016/j.resinv.2015.01.005. Epub 2015 Feb 26.

PMID:
25951098
26.

IGF2 preserves osteosarcoma cell survival by creating an autophagic state of dormancy that protects cells against chemotherapeutic stress.

Shimizu T, Sugihara E, Yamaguchi-Iwai S, Tamaki S, Koyama Y, Kamel W, Ueki A, Ishikawa T, Chiyoda T, Osuka S, Onishi N, Ikeda H, Kamei J, Matsuo K, Fukuchi Y, Nagai T, Toguchida J, Toyama Y, Muto A, Saya H.

Cancer Res. 2014 Nov 15;74(22):6531-41. doi: 10.1158/0008-5472.CAN-14-0914. Epub 2014 Oct 1.

27.

Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study.

Kato N, Iwase A, Sugita A, Goto M, Nakahara T, Nakamura T, Kondo M, Osuka S, Mori M, Saito A, Kikkawa F.

Gynecol Endocrinol. 2015 Jan;31(1):22-5. doi: 10.3109/09513590.2014.943720. Epub 2014 Jul 17.

PMID:
25030844
28.

Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model.

Saga I, Shibao S, Okubo J, Osuka S, Kobayashi Y, Yamada S, Fujita S, Urakami K, Kusuhara M, Yoshida K, Saya H, Sampetrean O.

Neuro Oncol. 2014 Aug;16(8):1048-56. doi: 10.1093/neuonc/nou096. Epub 2014 May 23.

29.

CXCL12 secreted from glioma stem cells regulates their proliferation.

Uemae Y, Ishikawa E, Osuka S, Matsuda M, Sakamoto N, Takano S, Nakai K, Yamamoto T, Matsumura A.

J Neurooncol. 2014 Mar;117(1):43-51. doi: 10.1007/s11060-014-1364-y. Epub 2014 Jan 19.

PMID:
24442483
30.

Clinical characteristics and neuroimaging findings in 12 cases of recurrent glioblastoma with communicating hydrocephalus.

Onuma K, Ishikawa E, Matsuda M, Hirata K, Osuka S, Yamamoto T, Masumoto T, Zaboronok A, Matsumura A.

Neurol Med Chir (Tokyo). 2013;53(7):474-81.

31.

Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab.

Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H, Matsuda M, Matsumura A.

Acta Neurochir Suppl. 2013;118:185-9. doi: 10.1007/978-3-7091-1434-6_34.

PMID:
23564129
32.

One-year follow-up of serum antimüllerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve?

Sugita A, Iwase A, Goto M, Nakahara T, Nakamura T, Kondo M, Osuka S, Mori M, Saito A, Kikkawa F.

Fertil Steril. 2013 Aug;100(2):516-22.e3. doi: 10.1016/j.fertnstert.2013.03.032. Epub 2013 Apr 8.

PMID:
23579006
33.

IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells.

Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, Okubo J, Fujita S, Takano S, Matsumura A, Saya H.

Stem Cells. 2013 Apr;31(4):627-40. doi: 10.1002/stem.1328.

34.

The patient had a normal magnetic resonance imaging and temporal lobe epilepsy secondary to a porencephalic cyst but showed structural lesions (hippocampal sclerosis).

Matsubara T, Ayuzawa S, Aoki T, Fujiomto A, Osuka S, Matsumura A.

Epilepsy Behav Case Rep. 2013 Sep 28;1:153-6. doi: 10.1016/j.ebcr.2013.08.005. eCollection 2013.

35.

Elevated diffusion anisotropy in gray matter and the degree of brain compression.

Osuka S, Matsushita A, Ishikawa E, Saotome K, Yamamoto T, Marushima A, Satou N, Zaboronok A, Masumoto T, Matsumura A.

J Neurosurg. 2012 Aug;117(2):363-71. doi: 10.3171/2012.4.JNS112305. Epub 2012 Jun 8.

PMID:
22680241
36.

Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain.

Osuka S, Takano S, Watanabe S, Ishikawa E, Yamamoto T, Matsumura A.

Neurol Med Chir (Tokyo). 2012;52(4):186-93.

37.

Can features of phosphate toxicity appear in normophosphatemia?

Osuka S, Razzaque MS.

J Bone Miner Metab. 2012 Jan;30(1):10-8. doi: 10.1007/s00774-011-0343-z. Epub 2012 Jan 5. Review.

38.

Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells.

Sampetrean O, Saga I, Nakanishi M, Sugihara E, Fukaya R, Onishi N, Osuka S, Akahata M, Kai K, Sugimoto H, Hirao A, Saya H.

Neoplasia. 2011 Sep;13(9):784-91.

39.

Mild encephalitis/encephalopathy with a reversible splenial lesion: evaluation by diffusion tensor imaging. Two case reports.

Osuka S, Imai H, Ishikawa E, Matsushita A, Yamamoto T, Nozue H, Ohto T, Saotome K, Komatsu Y, Matsumura A.

Neurol Med Chir (Tokyo). 2010;50(12):1118-22.

40.

Detection of failure of bevacizumab treatment for malignant glioma based on urinary matrix metalloproteinase activity.

Takano S, Mashiko R, Osuka S, Ishikawa E, Ohneda O, Matsumura A.

Brain Tumor Pathol. 2010 Oct;27(2):89-94. doi: 10.1007/s10014-010-0271-y. Epub 2010 Nov 3.

PMID:
21046310
41.

Diffusion tensor imaging in patients with adult chronic idiopathic hydrocephalus.

Osuka S, Matsumura A, Ishikawa E, Matsushita A.

Neurosurgery. 2010 Nov;67(5):E1474. doi: 10.1227/NEU.0b013e3181f3604b. No abstract available.

PMID:
20871429
42.

Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth.

Takano S, Kamiyama H, Mashiko R, Osuka S, Ishikawa E, Matsumura A.

J Neurooncol. 2010 Sep;99(2):177-85. doi: 10.1007/s11060-010-0118-8. Epub 2010 Jan 12.

PMID:
20066473
43.

Analysis of development of lesions in mice with serine palmitoyltransferase (SPT) deficiency -Sptlc2 conditional knockout mice-.

Ohta E, Ohira T, Matsue K, Ikeda Y, Fujii K, Ohwaki K, Osuka S, Hirabayashi Y, Sasaki M.

Exp Anim. 2009 Oct;58(5):515-24.

44.

Evaluation of ventriculomegaly using diffusion tensor imaging: correlations with chronic hydrocephalus and atrophy.

Osuka S, Matsushita A, Yamamoto T, Saotome K, Isobe T, Nagatomo Y, Masumoto T, Komatsu Y, Ishikawa E, Matsumura A.

J Neurosurg. 2010 Apr;112(4):832-9. doi: 10.3171/2009.7.JNS09550.

PMID:
19698041
45.

[Case report of germinoma with synchronous lesions in the thalamus and para lateral ventricle].

Takano S, Osuka S, Mashiko R, Matsumura A.

No Shinkei Geka. 2008 Jun;36(6):541-5. Japanese.

PMID:
18548896
46.

Endoscopic observation of pathophysiology of ventricular diverticulum.

Osuka S, Takano S, Enomoto T, Ishikawa E, Tsuboi K, Matsumura A.

Childs Nerv Syst. 2007 Aug;23(8):897-900. Epub 2007 Mar 27.

PMID:
17387491
47.

Long-term outcome of patients with intracranial germinoma.

Osuka S, Tsuboi K, Takano S, Ishikawa E, Matsushita A, Tokuuye K, Akine Y, Matsumura A.

J Neurooncol. 2007 May;83(1):71-9. Epub 2007 Jan 24.

PMID:
17245622
48.

Neurocysticercosis as solitary parenchymal lesion confirmed by mitochondrial deoxyribonucleic acid sequence analysis.

Ishikawa E, Komatsu Y, Kikuchi K, Yamasaki H, Kimura H, Osuka S, Tsurubuchi T, Ito A, Matsumura A.

Neurol Med Chir (Tokyo). 2007 Jan;47(1):40-4.

49.

p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.

Nishida K, Yamaguchi O, Hirotani S, Hikoso S, Higuchi Y, Watanabe T, Takeda T, Osuka S, Morita T, Kondoh G, Uno Y, Kashiwase K, Taniike M, Nakai A, Matsumura Y, Miyazaki J, Sudo T, Hongo K, Kusakari Y, Kurihara S, Chien KR, Takeda J, Hori M, Otsu K.

Mol Cell Biol. 2004 Dec;24(24):10611-20.

50.

Targeted disruption of the mouse 3-phosphoglycerate dehydrogenase gene causes severe neurodevelopmental defects and results in embryonic lethality.

Yoshida K, Furuya S, Osuka S, Mitoma J, Shinoda Y, Watanabe M, Azuma N, Tanaka H, Hashikawa T, Itohara S, Hirabayashi Y.

J Biol Chem. 2004 Jan 30;279(5):3573-7. Epub 2003 Nov 26.

Supplemental Content

Support Center